维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

10篇 您的检索式：作者名="Assenholt"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer显示文摘	Assenholt MS Petersen JB Nielsen SK	2008	Acta Oncol2008，47，7：	1
	2	Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer 显示文摘	ASSENHOLT M S VESTERGAARD A KALLEHAUGE JF	2014	Brachytherapy2014，16，7：	1
	3	A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer显示文摘	Assenholt MS Petersen JB Nielsen SK	2008	Acta Oncol2008，47，7：	1
	4	Implication of Ccr4-Not complex function in mRNA quality control in Saccharomyces cerevisiae 显示文摘	ASSENHOLT J MOUAIKEL J SAGUEZ C	2011	RNA2011，17，10：	1
	5	A dose planning study on applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer显示文摘	Kari Tanderup Marianne S. Assenholt Jorgen Petersen Soren K. Nielsen Jacob C. Lindegaard	2008	Brachytherapy2008，，2：	1
	6	Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer显示文摘	Marianne S. Assenholt Anne Vestergaard Jesper F. Kallehauge Sandy Mohamed S?ren K. Nielsen J?rgen B. Petersen Lars Fokdal Jacob C. Lindegaard Kari Tanderup	2014	Brachytherapy2014，，：	1
	7	A dose planning study on applicator guided stereotactic 1MRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer显示文摘	Assenholt M S Petersen J B Nielsen S K	2008	Acta Oncol2008，47，7：	1
	8	A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer显示文摘	Assenholt MS Petersen JB Nielsen SK	2008	Acta Oncol2008，47，：	1
	9	A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer显示文摘	Assenholt MS Petersen JB Nielsen SK	2008	Acta Oncol2008，47，7：	1
	10	Prevalence of Charles Bonnet syndrome in low vision:a systematic review and meta-analysis显示文摘Background:Charles Bonnet syndrome(CBS)is characterized by vivid lifelike visual hallucinations and is typically seen in individuals with visual impairment.In this systematic review,we summarize current knowledge on the prevalence of CBS in patients with low vision.Methods:We searched 11 literature databases on 21 April 2021 for studies on the prevalence of CBS in low vision populations.Our protocol was registered in the PROSPERO database(reg.No.CRD42021255021).Eligible studies were defined as those on a population of low vision patients wherein the prevalence of CBS was evaluated(without any further restriction on the method for diagnosis of CBS).No restriction was enforced on study design,but we expected observational cross-sectional studies due to the nature of our research question.Two authors independently extracted data and evaluated risk of bias of individual studies using the Agency for Healthcare Research and Quality checklist for cross-sectional studies.Studies underwent qualitative review in the text and quantitatively in a prevalence meta-analysis using the random-effects model.Sensitivity analysis was made to evaluate the robustness of the summary estimate.Results:We identified 11 studies,which summarized data on 4,521 individuals with visual impairment.Diagnosis of CBS was based on screening questions or interviews,which in positive cases often was explored in more detail with follow-up questions or interviews.Most studies either had normal mental state as a participant eligibility criterion or as a part of the diagnosis of CBS.The pooled prevalence of CBS in low vision patients aged≥40 years was 19.7%(95%CI:13.8%to 26.4%).The sensitivity analysis showed certain robustness in the summary prevalence estimate wherein prevalence estimates ranged from 16.9%to 22.5%.Conclusions:CBS is a prevalent condition in patients with low vision at a rate of approximately one in five patients.Considering that an estimated 239 million individuals have moderate visual impairment or worse,we estimate a global number of patients with CBS at approximately 47.2 million.	Yousif Subhi Mads Assenholt Nielsen Daniel Andrew Richard Scott Lars Morten Holm Amardeep Singh	2022	Annals of Eye Science2022，，2：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费